Advancing Obstructive Airway Disease Treatment: Dual PDE3/4 Inhibition as a Therapeutic Strategy
Obstructive airway diseases, including asthma and chronic obstructive pulmonary disease (COPD), evoke significant global health concerns manifested by airway inflammation and obstruction. Despite their differing origins, shared pathophysiological features and responses to therapeutic interventions h...
Saved in:
| Main Authors: | Rinzhin T. Sherpa, Cynthia J. Koziol-White, Reynold A. Panettieri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/9/659 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Haploinsufficiency of PDE2A causes in mice increased exploratory behavior associated with upregulation of neural nitric oxide synthase in the striatum
by: Ana Gabriela de Oliveira do Rêgo, et al.
Published: (2025-02-01) -
Menisoxoisoaporphine A, a novel oxoisoaporphine alkaloid from Menispermi Rhizoma, inhibits inflammation by targeting PDE4B
by: Xin Qiao, et al.
Published: (2024-12-01) -
Role of PDE4 Family in Cardiomyocyte Physiology and Heart Failure
by: Ivan Sherstnev, et al.
Published: (2025-03-01) -
PDE3A as a Therapeutic Target for the Modulation of Compartmentalised Cyclic Nucleotide-Dependent Signalling
by: Swaroop Ranjan Pati, et al.
Published: (2025-05-01) -
Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders
by: Min Kyu Park, et al.
Published: (2025-01-01)